Earnings
Lindt & Sprüngli slashes 2026 revenue growth outlook after European slump
Swiss chocolate maker cuts full-year organic revenue growth forecast to 0-2% from 4-6%, citing consumer price sensitivity and extreme summer heat in Europe.
Lindt & Sprüngli Cuts 2026 Sales Growth Forecast, Shares Drop
Swiss chocolate maker trims organic revenue growth outlook to 0–2% from 4–6%, citing European heat and consumer price sensitivity.
Calida lifts dividend and launches 2% share buyback, but analysts stay cautious
Swiss apparel group Calida announced a dividend payout increase to 40‑60% of adjusted earnings and a share repurchase of up to 2% of capital. Analysts say the moves improve returns but urge faster brand investment.
Verbio Reports Stronger Q4 Results; Biofuels Producer Skids in Premarket Trade
German biofuels maker Verbio posted fourth-quarter EBITDA of EUR 88.2 million, snapping a year-ago loss, but shares fell 0.8% premarket after full-year guidance missed investor expectations.
Peach Property Group Cuts Debt in Half, Beats Leverage Target on Track Early
The German-Swiss landlord reported a 25% rise in H1 adjusted EBITDA to EUR 30 million and cut total debt roughly in half, reaching its 2028 loan-to-value target two years ahead of schedule.
KWS SAAT Reports Resilient Margins as Sales Decline in FY 2025/26
German seedmaker posts €1.63 billion in sales, down 3%, but net income climbs 13% on FX gains and AgReliant deconsolidation. Shares fall 7.6%.
UBS Shares Fall as Capital Rules Weigh on Margins and Q2 Earnings Miss
UBS Group reported Q2 EPS of $0.87, below consensus, as proposed Swiss capital requirements threaten to cut earnings by up to 10%.
Swiss Economic Calendar: Sep 10–17 Covers Earnings, Inflation Data and Policy Meetings
Switzerland's key economic releases include BFS inflation figures, Repower and Helvetia Baloise half-year results, OECD country report, and UBS banking-law testimony before the Council of States.
Helvetia Baloise reports strong H1 results, raises synergy target
Swiss insurer posts underlying earnings of CHF 631.6m in first half, raising full-year synergy capture guidance to around 60% amid merger integration progress.
Helvetia Baloise posts 25.7% earnings rise in H1 2026, RoaE reaches 18.7%
The Swiss insurer reported CHF 632 million underlying earnings, a 25.7% jump year‑on‑year, and an annualised return on adjusted equity of 18.7%, beating its 16‑18% target.
Inter Cars Reports Strong H1 2026 Growth, Stock Dips 0.3%
Polish auto-parts distributor posts 19% international revenue growth and improves leverage; expansion in Germany and automation projects underpin long-term outlook.
Helvetia Baloise H1 Profit Drops on Merger Charges, Underlying Earnings Jump
Swiss insurer reports IFRS net income of 84.6M CHF, down sharply from 320.1M, hit by accelerated amortisation of 671.7M in merger intangibles; underlying earnings more than double to 631.6M.
Aevis Victoria lifts H1 2026 profit 30%, revenue edges up
The Swiss holding group posted a 30% rise in net profit to CHF 5.4 million, driven by stronger healthcare and hospitality margins.
Helvetia Baloise posts CHF 632M underlying H1 earnings, IFRS profit hit by merger write-down
Underlying earnings rose to CHF 631.6 million in the first half of 2026, while IFRS profit fell to CHF 84.6 million after a CHF 671.7 million accelerated write-down on intangible assets from the Baloise merger.
Helvetia Baloise posts strong H1 results with synergies ahead of schedule
Insurance giant reports CHF 631.6m underlying earnings for H1 2026, raising synergy outlook to around 60% of its CHF 650m long-term target.
Bioversys Posts Wider H1 Loss, Remains Funded Through 2028
Basel biotech reports CHF 15.6 mln net loss in first half, cites first Shionogi partnership revenue; cash runway extends to late 2028.
Partners Group reports H1 results; Layton steps down as CEO
Management income rises 6% to CHF 905m as AuM reaches USD 186bn; Co-CEOs Cagnati and Jenkner appointed effective January 2027.
Dermapharm posts 14% H1 EBITDA growth as shares rise 1.8%
German pharma group reports 5% revenue growth and 11% earnings rise in first half of 2026, lifts outlook amid strong branded product momentum.
Swiss economic calendar: Aug 25–Sep 1, 2026
Half-year earnings reports from Swiss companies alongside key macroeconomic data releases and industry events next week.
DroneShield posts 74% H1 2026 revenue growth, lifts FY guidance
Defense drone detection firm DroneShield reported AUD 126 million in first-half revenue, up 74% year-over-year, while reaffirming full-year guidance and flagging margin pressures from ERP and warehouse moves.
Coles FY26 profit jumps 13.7% as digital sales surge 26%
Supermarket giant posts record earnings growth, with eCommerce sales penetration rising to 15.7% in early FY27. Liquor segment EBIT plunges 47.8% amid restructuring costs.
Feintool posts H1 2026 profit rebound, shares rise 4%
Feintool International Holding AG reported a 5.6% rise in H1 sales, swung to a CHF 8.8 million EBIT and posted its first positive net result since 2023, sending the stock up about 4%.
Global economic calendar: Key events for Aug 27, 2026
Earnings season continues with German, French and U.S. companies reporting quarterly figures while central bank data and labor indicators take center stage in Europe and the U.S.
Gurit raises H1 2026 outlook, shares surge 19.45% on earnings
Swiss composites maker Gurit upgraded its full-year 2026 sales and margin guidance after posting a 16% rise in continuing operations revenue for H1 2026, with adjusted operating profit up 82% to CHF 16.9 million.